Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

Nuedexta Testing New Indication

By Drug Discovery Trends Editor | June 13, 2012

ALISO VIEJO, Calif. (AP) – Avanir Pharmaceuticals Inc. said it is planning to test its drug Nuedexta as a treatment for agitation in Alzheimer’s disease patients.

The company it will start a midstage trial of the drug by September. Nuedexta is a treatment for pseudobulbar affect, a condition that involves involuntary emotional outbursts like laughing or crying. It is associated with brain disease or injury. The FDA approved it in February 2011. Avanir is also studying the drug as a treatment for nerve pain in multiple sclerosis and diabetes.

Avanir said large numbers of Alzheimer’s disease patients develop behavioral and psychiatric symptoms, including more than 80% of patients in nursing homes.

Date: June 11, 2012
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

4D Path/PathPresenter
How 4D Path and PathPresenter aim to further AI-enabled digital pathology for breast tumor profiling
Moderna
Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
Lab facility
Massachusetts is competing for ARPA-H biomedical research center
Blockchain
Startup vies to get blockchain adoption in pharma off the ground

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50